Full name
VITASYNTH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.10.Z - Manufacture of basic pharmaceutical products
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.38.Z - Wholesale trade of other food products
46.39.Z - Wholesale trade of non-specialized food, beverages, and tobacco products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
47.29.Z - Retail trade
64.92.Z - Other forms of credit granting
71.20.A - Food quality testing and analysis
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 2,7 | 5,3 | 1,9 | -64,9 |
Gross profit (loss) | 3,4 | 5,6 | 1,7 | -70 |
EBITDA | 3,7 | 5,9 | 2,6 | -55,1 |
Short time liabilities | 1,2 | 0,3 | 4,3 | 1315,2 |
Other operating costs | 0 | 0 | 0 | 37,6 |
Equity capital | 7,1 | 14,7 | 16,3 | 11,5 |
Operating profit (EBIT) | 3,3 | 5,6 | 2,1 | -62,4 |
Assets | 8,3 | 15 | 26,7 | 78,2 |
Net profit (loss) | 2,7 | 5,6 | 1,7 | -70 |
Cash | 0,9 | 2,2 | 0,6 | -71,7 |
Net income from sale | 9,1 | 9,4 | 9,8 | 4,4 |
Liabilities and provisions for liabilities | 1,2 | 0,3 | 10,3 | 3297,1 |
Working assets | 5,2 | 9,6 | 7,7 | -19,2 |
Other income costs | 0,7 | 0,3 | 0,3 | -19,1 |
Depreciation | 0,4 | 0,2 | 0,5 | 118,9 |
% | % | % | p.p. | |
Profitability of capital | 38,3 | 38,2 | 10,3 | -27,9 |
Equity capital to total assets | 85,1 | 98 | 61,3 | -36,7 |
Gross profit margin | 37,1 | 59,4 | 17,1 | -42,3 |
EBITDA Margin | 41 | 62,2 | 26,7 | -35,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 50 | 12 | 159 | 147 |
Current financial liquidity indicator | 4.187798023223877 | 31.57493019104004 | 1.8023558855056763 | -29,8 |
Net dept to EBITDA | -0.24191248416900635 | -0.3777753412723541 | 3.3792145252227783 | 3,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane